Sino Medical Sciences Technology In Tangible Net Worth Ratio
Sino Medical Sciences Technology In tangible net worth ratio. Sino Medical Sciences Technology In (688108) has a Tangible Net Worth Ratio of 46.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥571.18 Million) from net assets (CN¥1.07 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 688108 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Sino Medical Sciences Technology In (2016–2025)
Tangible net worth ratio of Sino Medical Sciences Technology In from 2016 to 2025. This chart shows how Sino Medical Sciences Technology In's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 46.7%, reflecting net assets of CN¥1.07 Billion with intangible assets of CN¥571.18 Million CNY. See Sino Medical Sciences Technology In (688108) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Sino Medical Sciences Technology In Tangible Net Worth Ratio by Year (2016–2025)
Sino Medical Sciences Technology In tangible net worth ratio by year from 2016 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Sino Medical Sciences Technology In from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Sino Medical Sciences Technology In.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.4% | CN¥2.28 Billion | CN¥584.95 Million | CN¥1.35 Billion | ▲ +39.2 pp |
| 2024 | 35.2% | CN¥898.34 Million | CN¥582.39 Million | CN¥1.30 Billion | ▼ -20.9 pp |
| 2023 | 56.1% | CN¥861.65 Million | CN¥378.11 Million | CN¥1.19 Billion | ▼ -3.9 pp |
| 2022 | 60.1% | CN¥887.48 Million | CN¥354.50 Million | CN¥1.07 Billion | ▼ -6.7 pp |
| 2021 | 66.7% | CN¥945.16 Million | CN¥314.47 Million | CN¥1.10 Billion | ▼ -5.2 pp |
| 2020 | 72.0% | CN¥1.08 Billion | CN¥302.04 Million | CN¥1.22 Billion | ▼ -4.6 pp |
| 2019 | 76.6% | CN¥1.10 Billion | CN¥257.52 Million | CN¥1.21 Billion | ▼ -0.1 pp |
| 2018 | 76.6% | CN¥701.28 Million | CN¥163.99 Million | CN¥806.10 Million | ▼ -4.5 pp |
| 2017 | 81.1% | CN¥606.70 Million | CN¥114.54 Million | CN¥710.33 Million | ▲ +18.2 pp |
| 2016 | 62.9% | CN¥202.75 Million | CN¥75.23 Million | CN¥280.81 Million | — |